Dr. Pamela Nathan DHM L.Ac. has been delivering health to your front door since 1998. Happy patients in over 78 countries. Want an Appointment? Book Now

Free Shipping Over $69**

Shopping Cart

Your cart is currently empty.

Lactobacillus Fermentum ME – 3 References

Lactobacillus Fermentum ME – 3 References

Lactobacillus Fermentum M – E is a renown strain of probiotics that shows by using extensive research, to naturally produce glutathione, known as the master antioxidant in the human body. Glutathione is very well known for its antioxidant characteristics. It also helps with detoxification as well as helping the support the immune system.

Lactobacillus Fermentum M-E is included in Essential Formula’s Reg’activ formulas for Cardio support, Immune Support and Detoxification.

1. Konstantinidis KT, Tiedje JM, Towards a Genome-Based Taxonomy for Prokaryotes. J Bacteriol. Sep 2005; 187(18):6258-6264

2. Mikelsaar M, Zilmar M., Lactobacillus fermentum ME-3… Microb Ecol Health Dis. Apr 2009;21(1):1-27.

3. Sepp E., et al., Intestinal microflora of Estonian and Swedish infants. Acta Paediatr. 1997 Sept;86(9):956-61

4. Mikelsaar M., Probiotic lactobacilli in antioxidative defence.

5. UT Professor Marika Mikelsaar Receives Prestigious EU Award:

6. Kullisaar T., et al., Complete glutathione system in probiotic Lactobacillus fermentum ME-3. Applied Biochemistry & Microbiology; Sep 2010,46(5):481.

7. US Patent, 20040151708 A1: http://www.google.com/patents/US20040151708

8. Fariss MW. et al., Role of Mitochondria in Toxic Oxidative Stress. Molecular Interventions. April 20015;5(2):94-111.

9. Hutt P, et al… Journal of Applied Microbiology. 2006; Vol.100:1324-1332.

10. Central European Journal of Biology 2011, vol. 6(1).

11. Holvoet P. Acta Cardiol. 2004 Oct;59(5):479-84.

12. Pastore A., et al., Analysis of glutathione:Implication in redox and detoxification. Clin Chim Acta. 2003 Jul 1:333(1);19-39.

13. Wu G., et al., Glutathione metabolism and its implications for health. J Nutr. 2004 Mar;134(3):489-92.

14. US Patent WO 2014102692 A1: Method of treatment using Lactobacillus fermentum ME-3. http://www.google.com/patents/WO2014102692A1?cl=en

15. Casida J, Quistad G., (2004). Organophosphate Toxicology: Safety Aspects of Nonacetylcholinesterase Secondary Targets. Chemical Research in Toxicology, Vol. 17, No.8, pp. 983-992.

16. Songisepp E. Evaluation of technilogical and functional properties of the new probiotic  Lactobacillus fermentum ME-3. Diss Med Univ Tartuensis; 2005.

Copyright © 2018 Ecology Health Center / Crohns.net - HealthyLifeUSA.